First patient in the world treated with Alpha DaRT® in the brain – - According to the National Brain Tumor Society, ...

Alpha Tau Medical Ltd ( ($DRTS) ) has shared an update. On December 9, 2025, Alpha Tau Medical Ltd. announced the successful treatment of the ...

I am delighted that exciting additional pancreatic cancer study data will be presented for a second consecutive year at the ...

Alpha Tau Medical Ltd ( ($DRTS) ) has provided an announcement. On December 2, 2025, Alpha Tau Medical Ltd. announced that it received FDA ...

JERUSALEM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT®, today announced that the FDA has ...

Alpha Tau Medical Ltd. announced significant advancements in their alpha-radiation cancer treatment, Alpha DaRT®, during the 2025 ASCO GI Symposium and R&D Update Day. Interim results from three ...

Alpha Tau reports promising Alpha DaRT trial results in pancreatic cancer and head and neck cancer, with significant survival benefits. High disease control rate (91% DCR) and positive interim safety ...

First patient in the world treated with Alpha DaRT- in the brain - - According to the National Brain Tumor Society, ...